コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tor 1F, natriuretic precursor peptide B, and neuromedin B.
2 eristic of the GRPr: bombesin > or = GRP > > neuromedin B.
3 esin(5-14) which has the sequence [Gln3,Arg6]neuromedin B.
4 in adulthood by the expression of Phox2b and neuromedin B.
5 ignificant upregulation of 1080 genes (e.g., neuromedin B), and a significant downregulation of 518 g
6 r 15 (GDF15), angiopoietin-like 6 (Angptl6), neuromedin B, and nesfatin, linked to energy expenditure
7 N) that express the bombesin-related peptide Neuromedin-B are proposed to be important in this proces
8 atin M, we also detected increased levels of neuromedin B in fibroblasts of CNPG lesions compared wit
9 dization, we show here that a single marker, Neuromedin B mRNA (Nmb), identifies RTN neurons in roden
11 ptides, including gastrin-releasing peptide, neuromedin B, neurotensin, gastrin, cholecystokinin and
14 o uncover the expression of the neuropeptide neuromedin B (NMB) in the trigeminal ganglia of mice.
17 ased by nasal sensory neurons, we found that neuromedin B (NMB) peptide is essential for signaling sn
18 opeptides gastrin-releasing peptide (GRP) or neuromedin B (NMB) produced a large membrane depolarizat
19 he gastrin-releasing peptide (GRP) receptor, neuromedin B (NMB) receptor, or BLP receptor subtype 3]
25 eptides [gastrin-releasing peptide (GRP) and neuromedin B (NMB)] are important in numerous biological
26 ction in PHOX2B expression in chemosensitive neuromedin-B (NMB) expressing neurons in the RTN altered
27 dence suggests that bombesin-related peptide Neuromedin-B (Nmb) expression identifies chemoreceptor n
28 chymase (CMA1), tryptase (TPS1) and mastin, neuromedin-B (NMB), nerve growth factor (NGF), and leuko
29 of mRNA for the three BLP receptor subtypes (neuromedin B [NMB]) receptor, gastrin-releasing peptide
30 omedin B to Rat-1 cells transfected with the neuromedin B preferring receptor also activated p42(mapk
32 y conserved G-protein-coupled receptors: the neuromedin B-preferring, the gastrin-releasing peptide-p
33 pecifically to GRP-R (0.8 nmol/L) and to the neuromedin B receptor (NMB-R) (0.9 nmol/L), with no affi
34 hares high homology with bombesin receptors (neuromedin B receptor (NMB-R) and gastrin-releasing pept
35 gastrin-releasing peptide receptor (GRP-R), neuromedin B receptor (NMB-R), and bombesin receptor sub
36 trin-releasing peptide receptor (GRP-R), the neuromedin B receptor (NMB-R), and bombesin receptor sub
37 trin-releasing peptide receptor (GRP-R), the neuromedin B receptor (NMB-R), bombesin receptor subtype
38 , functions through a distinct receptor, the neuromedin B receptor (NMB-R), of which little is known
39 -releasing peptide receptor (GRP-R, or bb2), neuromedin B receptor (NMB-R, or bb1), and the bombesin
42 ma cells which possess native NMB-Rs and rat neuromedin B receptor (rNMR-R) transfected BALB 3T3 cell
43 gastrin-releasing peptide receptor (GRP-R), neuromedin B receptor, and bombesin receptor subtype 3.
45 NAs encoding bombesin receptor subtype 3 and neuromedin-B receptor (NMB-R), but not gastrin-releasing
46 or subtype (BRS)-1 (GRP receptor) and BRS-2 (neuromedin-B receptor), but the mRNA for GRP ligand was
47 hat antagonists of gastrin-releasing peptide/neuromedin B receptors (BB/BB) PD168368 [(S)-a-methyl-a-
48 f CNPG lesions compared with AD and HC, with neuromedin B receptors detectable on some nerve endings.
50 ily, including gastrin-releasing peptide and neuromedin B, which are found in axons in the mediobasal